TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 139 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $69,000 | +13.1% | 51,274 | -4.7% | 0.00% | – |
Q4 2018 | $61,000 | -51.6% | 53,787 | +17.7% | 0.00% | – |
Q3 2018 | $126,000 | -22.2% | 45,687 | +0.9% | 0.00% | – |
Q2 2018 | $162,000 | -50.0% | 45,282 | -11.9% | 0.00% | – |
Q4 2017 | $324,000 | -8.2% | 51,382 | -0.5% | 0.00% | – |
Q3 2017 | $353,000 | +3.8% | 51,639 | +8.4% | 0.00% | – |
Q2 2017 | $340,000 | -57.8% | 47,633 | -45.7% | 0.00% | – |
Q1 2017 | $806,000 | +475.7% | 87,682 | +152.8% | 0.00% | – |
Q4 2016 | $140,000 | +17.6% | 34,690 | +11.7% | 0.00% | – |
Q3 2016 | $119,000 | -10.5% | 31,067 | +0.7% | 0.00% | – |
Q2 2016 | $133,000 | -93.8% | 30,843 | -31.3% | 0.00% | -100.0% |
Q2 2015 | $2,129,000 | +29.4% | 44,883 | -0.0% | 0.00% | 0.0% |
Q1 2015 | $1,645,000 | +18.9% | 44,895 | +28.9% | 0.00% | 0.0% |
Q4 2014 | $1,383,000 | -11.5% | 34,817 | -55.5% | 0.00% | 0.0% |
Q3 2014 | $1,562,000 | +2197.1% | 78,303 | +1466.1% | 0.00% | – |
Q4 2013 | $68,000 | +47.8% | 5,000 | +25.0% | 0.00% | – |
Q3 2013 | $46,000 | – | 4,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rhenman & Partners Asset Management AB | 300,000 | $1,209,000 | 0.23% |
Rock Springs Capital Management LP | 698,000 | $2,813,000 | 0.19% |
Eventide Asset Management | 600,000 | $2,418,000 | 0.16% |
Teza Capital Management LLC | 14,369 | $58,000 | 0.08% |
Candriam S.C.A. | 374,000 | $1,507,000 | 0.04% |
R&F Capital Advisors LP | 23,778 | $96,000 | 0.03% |
Tekla Capital Management LLC | 192,322 | $775,000 | 0.03% |
Sunbelt Securities, Inc. | 6,000 | $24,180,000 | 0.03% |
DOW CHEMICAL CO /DE/ | 65,000 | $249,000 | 0.03% |
CANADA PENSION PLAN INVESTMENT BOARD | 1,654,100 | $6,666,000 | 0.02% |